4.1 Article

Telling bad news to the elderly cancer patients: The role of family caregivers in the choice of non-disclosure - The Gruppo Italian di Oncologia Geriatrica (GIOGer) Study

Journal

JOURNAL OF GERIATRIC ONCOLOGY
Volume 1, Issue 2, Pages 73-80

Publisher

ELSEVIER
DOI: 10.1016/j.jgo.2010.07.002

Keywords

Geriatric oncology; Patient-physician communication

Funding

  1. Italian Min San

Ask authors/readers for more resources

Purpose: We investigated the caregiver's role in the choice of non-disclosure in patient-physician communication. Patients and Methods: A total of 194 family caregivers of partially informed (PI) or not-informed (NI) elderly cancer patients participated in the study protocol. PI patients received only approximate information aimed at reassurance; NI patients had no access to any information regarding their health status. The family caregiver, identified by the patient, underwent an interview regarding patient-physician communication. Results: As many as 35.2% (n=74) were caregivers for NI and 64.8% (n=136) for PI. Patients living with their spouse were better informed than patients living with their children (80.0% vs. 58.7%; p=0.02). The decision to not inform the patients mainly arose in the family (86.1% vs. 77.0% of NI and PI, respectively, p=0.12) and was due to the psychological frailty of the patient (52.8% NI vs. 32.8% PI, p=0.006) and to the fear of severe emotional distress during a fully disclosing patient-physician communication (67.0%). Caregivers for PI patients were more concerned sharing information on the prognosis (48.4%), while caregivers for NI patients were more concerned sharing information on diagnosis (44.4%). Conclusions: The choice of non-disclosure was independent from an explicit request of the patient and was associated with the caregiver's fears and needs. Because elderly patients rely on a family caregiver to cope with their disease, early intervention tailored to caregiver's needs and skills are necessary. Such interventions will avoid the risk of caregiver distress and help medical staff in managing the various aspects of clinical communication with the elderly cancer patients. (C) 2010 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

The impact of cancer on the risk of death with a functioning graft of Italian kidney transplant recipients

Martina Taborelli, Diego Serraino, Claudia Cimaglia, Lucrezia Furian, Luigi Biancone, Ghil Busnach, Paola Todeschini, Nicola Bossini, Maurizio Iaria, Maria R. Campise, Massimiliano Veroux, Franco Citterio, Andrea Ambrosini, Vincenzo Cantaluppi, Margherita Mangino, Francesco Pisani, Giuseppe Tisone, Marco Fiorentino, Davide Argiolas, Flavia Caputo, Pierluca Piselli

Summary: This study found that cancer has a significant impact on the risk of death with a functioning graft in kidney transplant recipients. Those with cancer had a 3.31 times higher risk of death compared to recipients without cancer. Different types of cancer showed varying levels of risk, with the effect being more pronounced within the first year following cancer diagnosis.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Immunology

Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study

Angela Marie Abbatecola, Raffaele Antonelli Incalzi, Alba Malara, Annapina Palmieri, Anna Di Lonardo, Giorgio Fedele, Paola Stefanelli, Gilda Borselli, Marcello Russo, Marianna Noale, Stefano Fumagalli, Pietro Gareri, Enrico Mossello, Caterina Trevisan, Stefano Volpato, Fabio Monzani, Alessandra Coin, Giuseppe Bellelli, Chukwuma Okoye, Susanna Del Signore, Gianluca Zia, Elisa Bottoni, Carmine Cafariello, Graziano Onder

Summary: The COVID-19 pandemic has significantly impacted routine care for older individuals, particularly those living in long term care facilities. The vaccination of older adults in LTC facilities against COVID-19 is crucial in protecting them from infection and death. The GeroCovid Vax study in Italy aims to investigate the safety and efficacy of anti-SARS-CoV-2 vaccines in this population.

VACCINE (2022)

Editorial Material Gerontology

Disentangling the impact of COVID-19 infection on clinical outcomes and preventive strategies in older persons: an Italian perspective

Angela Marie Abbatecola, Raffaele Antonelli Incalzi, Alba Malara, Annapina Palmieri, Anna Di Lonardo, Gilda Borselli, Marcello Russo, Marianna Noale, Stefano Fumagalli, Pietro Gareri, Enrico Mossello, Caterina Trevisan, Stefano Volpato, Fabio Monzani, Alessandra Coin, Giuseppe Bellelli, Chukwuma Okoye, Susanna Del Signore, Gianluca Zia, Elisa Bottoni, Carmine Cafariello, Graziano Onder

Summary: This article discusses the reports from different clinical settings in Italy during the COVID-19 pandemic and emphasizes the importance of two large population-based prospective studies.

JOURNAL OF GERONTOLOGY AND GERIATRICS (2022)

Article Microbiology

In vitro Evaluation of Antiviral Efficacy of a Standardized Hydroalcoholic Extract of Poplar Type Propolis Against SARS-CoV-2

Giuseppe Sberna, Marco Biagi, Giovanni Marafini, Roberta Nardacci, Mirella Biava, Francesca Colavita, Pierluca Piselli, Elisabetta Miraldi, Gianpiero D'Offizi, Maria Rosaria Capobianchi, Alessandra Amendola

Summary: Propolis, a honeybee's product, has been found to have antiviral activity against SARS-CoV-2, the virus that causes COVID-19. It can inhibit viral replication, limit the spread of the virus, and protect host cells from infection.

FRONTIERS IN MICROBIOLOGY (2022)

Article Immunology

Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19

Valentina Mazzotta, Alessandro Cozzi-Lepri, Francesca Colavita, Simone Lanini, Silvia Rosati, Eleonora Lalle, Ilaria Mastrorosa, Claudia Cimaglia, Alessandra Vergori, Nazario Bevilacqua, Daniele Lapa, Andrea Mariano, Aurora Bettini, Chiara Agrati, Pierluca Piselli, Enrico Girardi, Concetta Castilletti, Anna Rosa Garbuglia, Francesco Vaia, Emanuele Nicastri, Andrea Antinori

Summary: This study compared the effectiveness of different monoclonal antibodies (mAbs), Bamlanivimab/Etesevimab (BAM/ETE) and Casirivimab/Imdevimab (CAS/IMD), in patients with early mild-to-moderate COVID-19. The results showed that CAS/IMD reduced the risk of clinical progression compared to BAM/ETE, but there was no significant difference in virological response.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, General & Internal

Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH

Roberta Gagliardini, Alessandra Vergori, Patrizia Lorenzini, Stefania Cicalini, Carmela Pinnetti, Valentina Mazzotta, Annalisa Mondi, Ilaria Mastrorosa, Marta Camici, Simone Lanini, Marisa Fusto, Jessica Paulicelli, Maria Maddalena Plazzi, Luisa Marchioni, Chiara Agrati, Anna Rosa Garbuglia, Pierluca Piselli, Emanuele Nicastri, Fabrizio Taglietti, Fabrizio Palmieri, Gianpiero D'Offizi, Enrico Girardi, Francesco Vaia, Andrea Antinori

Summary: Compared to non-PLWH, PLWH hospitalized with COVID-19 showed milder symptoms, but no significant difference in clinical outcomes could be observed.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Infectious Diseases

The impact of COVID-19 vaccination programme in the Republic of San Marino: Focus on effectiveness of Gam-Covid-Vac

Giuseppe Tonnara, Pierluca Piselli, Claudia Cimaglia, Massimo Arlotti, Elena Sacchini, Samanta Manoni, Antonio Zani, Fausto Muccioli, Anna Laderchi, Sergio Rabini, Andrea Antinori, Francesco Vaia, Emanuele Nicastri, Enrico Girardi

Summary: This study investigated the impact and effectiveness of the Gam-COVID-Vac vaccination program in the Republic of San Marino. It found that the overall effectiveness of the vaccine was 67.6% against SARS-CoV-2 infection and 87.9% against COVID-19-related hospitalizations. The effectiveness of Gam-COVID-Vac peaked at 91.8% in the first two months after the second dose but declined to 57.8% at six months. The study concluded that the vaccine provided sustainable effectiveness against COVID-19-related hospitalizations.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Article Medicine, General & Internal

Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study

Caterina Trevisan, Valeria Raparelli, Alba Malara, Angela Marie Abbatecola, Marianna Noale, Annapina Palmieri, Giorgio Fedele, Anna Di Lonardo, Pasqualina Leone, Ilaria Schiavoni, Paola Stefanelli, Stefano Volpato, Raffaele Antonelli Incalzi, Graziano Onder

Summary: This study examined the COVID-19 infections, adverse events, and humoral response after vaccination in long-term care facility (LTCF) residents. The results showed that only 12.1% of vaccinated residents got COVID-19 during the 12-month follow-up, with no sex differences. Local adverse reactions were more common in females. The antibody response was influenced by sex-specific comorbidities.

INTERNAL AND EMERGENCY MEDICINE (2023)

Article Infectious Diseases

The possible effect of sociobehavioral factors and public health actions on the mpox epidemic slowdown

Francesco Vairo, Sara Leone, Valentina Mazzotta, Pierluca Piselli, Gabriella De Carli, Simone Lanini, Fabrizio Maggi, Emanuele Nicastri, Roberta Gagliardini, Serena Vita, Andrea Siddu, Giovanni Rezza, Alessandra Barca, Francesco Vaia, Andrea Antinori, Enrico Girardi

Summary: A pre-exposure vaccination campaign was initiated in Italy in August 2022 to prevent the spread of mpox virus. This study explores the factors affecting the trend of mpox cases in the Lazio region of Italy, which had a rapid roll-out of the vaccination campaign, through a Poisson segmented regression model.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Virology

Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes

Annalisa Mondi, Ilaria Mastrorosa, Pierluca Piselli, Claudia Cimaglia, Giulia Matusali, Fabrizio Carletti, Giuseppina Giannico, Eugenia Milozzi, Elisa Biliotti, Silvia Di Bari, Pierangelo Chinello, Alessia Beccacece, Francesca Faraglia, Pietro Vittozzi, Silvia Mosti, Nardi Tetaj, Giulia Valeria Stazi, Carmela Pinnetti, Marta Camici, Alberto D'Annunzio, Alessandra Marani, Lavinia Fabeni, Eliana Specchiarello, Cesare Ernesto Maria Gruber, Alberta Villanacci, Sabrina Minicucci, Anna Rosa Garbuglia, Stefania Ianniello, Luisa Marchioni, Fabrizio Taglietti, Gianpiero D'Offizi, Fabrizio Palmieri, Emanuele Nicastri, Fabrizio Maggi, Francesco Vaia, Enrico Girardi, Andrea Antinori

Summary: In the first quarter of 2022, Omicron rapidly displaced Delta and became prevalent in hospitalized COVID-19 adults. Although Omicron infections showed a less severe clinical presentation, there were no substantial differences in clinical progression compared to Delta infections. This suggests that any hospitalization, especially in more vulnerable individuals, may be at risk for severe progression, which is more related to the underlying frailty of patients rather than the intrinsic severity of the viral variant.

JOURNAL OF MEDICAL VIROLOGY (2023)

Letter Geriatrics & Gerontology

Promoting and Building Long-Term Care Health Research Networks: GeroCovid Observational and Gerocovid Vax Initiatives

Angela Marie Abbatecola, Raffaele Antonelli Incalzi, Giuseppe Bellelli, Gilda Borselli, Carmine Cafariello, Alessandra Coin, Stefania Del Signore, Susanna Del Signore, Stefano Fumagali, Pietro Gareri, Alba Malara, Enrico Mossello, Fabio Monzani, Marianna Noale, Chukwuma Okoye, Graziano Onder, Caterina Trevisan, Stefano Volpato, Gianluca Zia

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2023)

Article Oncology

Variation in Post-Transplant Cancer Incidence among Italian Kidney Transplant Recipients over a 25-Year Period

Pierluca Piselli, Diego Serraino, Claudia Cimaglia, Lucrezia Furian, Luigi Biancone, Ghil Busnach, Nicola Bossini, Paola Todeschini, Maurizio Iaria, Franco Citterio, Mariarosaria Campise, Massimiliano Veroux, Giuseppe Tisone, Vincenzo Cantaluppi, Margherita Mangino, Simona Simone, Davide Argiolas, Andrea Ambrosini, Francesco Pisani, Flavia Caputo, Martina Taborelli

Summary: This cohort study examined cancer incidence among 11,418 Italian recipients of kidney transplantation over a 25-year period. The study found a decreased risk of Kaposi's sarcoma, but no significant changes in the incidence of other cancers over time. It highlights the need for continued cancer prevention efforts in kidney transplant recipients.

CANCERS (2023)

Article Endocrinology & Metabolism

Diabetes Affects Antibody Response to SARS-CoV-2 Vaccination in Older Residents of Long-term Care Facilities: Data From the GeroCovid Vax Study

Enrico Virgilio, Caterina Trevisan, Angela Abbatecola, Alba Malara, Annapina Palmieri, Giorgio Fedele, Paola Stefanelli, Pasqualina Leone, Ilaria Schiavoni, Stefania Maggi, Stefano Volpato, Raffaele Antonelli Incalzi, Graziano Onder

Summary: Type 2 diabetes may weaken the antibody response to COVID-19 vaccination in older residents of LTCFs, but insulin treatment could mitigate this effect and establish similar humoral immunity as individuals without diabetes.

DIABETES CARE (2022)

Article Geriatrics & Gerontology

Humoral immunity induced by mRNA COVID-19 vaccines in Nursing Home Residents previously infected with SARS-CoV-2

Giorgio Fedele, Annapina Palmieri, Cecilia Damiano, Anna Di Lonardo, Pasqualina Leone, Ilaria Schiavoni, Caterina Trevisan, Angela Marie Abbatecola, Carmine Cafariello, Alba Malara, Pasquale Minchella, Giuseppina Panduri, Raffaele Antonelli Incalzi, Anna Teresa Palamara, Paola Stefanelli, Graziano Onder

Summary: This study aimed to monitor antibody levels in nursing home residents with a history of prior SARS-CoV-2 infection over a six-month period. The results showed that prior infection was associated with a stronger immune response to vaccination, and a longer interval between infection and vaccination was correlated with a better antibody response.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2022)

Article Medicine, General & Internal

Timing and Outcomes of Noninvasive Ventilation in 307 ARDS COVID-19 Patients: An Observational Study in an Italian Third Level COVID-19 Hospital

Nardi Tetaj, Pierluca Piselli, Sara Zito, Giada De Angelis, Maria Cristina Marini, Dorotea Rubino, Ilaria Gaviano, Maria Vittoria Antonica, Elisabetta Agostini, Candido Porcelli, Giulia Valeria Stazi, Gabriele Garotto, Donatella Busso, Silvana Scarcia, Assunta Navarra, Claudia Cimaglia, Simone Topino, Fabio Iacomi, Alessandra D'Abramo, Carmela Pinnetti, Gina Gualano, Alessandro Capone, Alberta Villanacci, Andrea Antinori, Fabrizio Palmieri, Gianpiero D'Offizi, Stefania Ianniello, Fabrizio Taglietti, Paolo Campioni, Francesco Vaia, Emanuele Nicastri, Enrico Girardi, Luisa Marchioni

Summary: This study found that NIV failure in COVID-19 ARDS patients is correlated with the severity of the disease. In COVID-19 patients, starting NIV treatment appears to increase its effectiveness and reduce the risk of intubation and/or death for patients with mild ARDS (P/F > 200 mmHg). Additionally, early NIV treatment seems to decrease the risk of ICU mortality at 28 days from ICU admission.

MEDICINA-LITHUANIA (2022)

Article Oncology

Longitudinal changes in cognitive and physical function and health-related quality of life in older adults with acute myeloid leukemia

Vijaya R. Bhatt, Christopher Wichman, Thuy T. Koll, Alfred L. Fisher, Tanya M. Wildes, Ann Berger, James O. Armitage, Sarah A. Holstein, Lori J. Maness, Krishna Gundabolu

Summary: A study on older adults with AML receiving chemotherapy showed significant comorbidity burden and functional impairments at baseline, but cognitive and physical function improvements or stability, as well as improved depression scores, were observed in a high proportion of patients at three months post-treatment, indicating success of treatment.

JOURNAL OF GERIATRIC ONCOLOGY (2024)

Correction Oncology

Hospitalization due to adverse drug events in older adults with cancer: A retrospective analysis (vol 14,101540, 2023)

Darren J. Walsh, Laura J. Sahm, Michelle O'Driscoll, Bronagh Bolger, Hitam Ameen, Michelle Hannan, Caitriona Goggin, Anne M. Horgan

JOURNAL OF GERIATRIC ONCOLOGY (2024)

Article Oncology

Risk of dementia among older patients with lymphoma: A Danish nationwide matched cohort study

Eva Futtrup Maksten, Lasse Hjort Jakobsen, Boris Modrau, Hilde Jensvoll, Kristian Hay Kragholm, Judit Meszaros Jorgensen, Michael Roost Clausen, Robert Schou Pedersen, Andriette Dessau-Arp, Thomas Stauffer Larsen, Christian Bjorn Poulsen, Anne Ortved Gang, Peter Brown, Tarec C. El-Galaly, Marianne Tang Severinsen

Summary: The risk of developing dementia is not increased after lymphoma treatment among patients.

JOURNAL OF GERIATRIC ONCOLOGY (2024)

Review Oncology

Self-reported electronic symptom monitoring in older patients with multimorbidity treated for cancer: Development of a core dataset based on expert consensus, literature review, and quality of life questionnaires

P. A. L. Nelleke Seghers, Marije E. Hamaker, Shane O'Hanlon, Johanneke E. A. Portielje, Hans Wildiers, Pierre Soubeyran, Annemarie Coolbrandt, Siri Rostoft

Summary: This study identified a core set of symptoms to monitor in older patients with multimorbidity treated for cancer. These symptoms include those related to cancer, treatment side effects, functional decline, and destabilization of comorbidities. The results provide a basis for guiding symptom monitoring during cancer treatment.

JOURNAL OF GERIATRIC ONCOLOGY (2024)